EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advances in understanding lipid metabolism in oligodendrocyte development and neurodegenerative diseases

Qing-Qing Sun, Ming-Yue Bao, Rui Gao, Shu-Kun Wang, Yao Zhang, Li-Bin Wang, Yuan Zhang iD, Xing Li iD

Clinical Science · 2026

DOI: 10.1042/cs20258150 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Science, 2026. Verfasst von Qing-Qing Sun und 7 weiteren Autor:innen. Beteiligte Einrichtung: National Engineering Laboratory for Resource Development of Endangered Crude Drugs in Northwest China, The Key Laboratory of Medicinal Resources and …. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Lipid Metabolism, Oligodendroglia. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 164 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Scientific Research Program Funded by Education Department of Shaanxi Provincial Government, Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lipids are indispensable architectural and functional components of central nervous system (CNS) myelin, with cholesterol, sphingolipids, and phospholipids collectively constituting 70%–80% of myelin membrane composition. Oligodendrocytes (OLs), the sole myelin-producing cells in the CNS, exhibit exquisite metabolic specialization to sustain lifelong myelination and remyelination. Mounting evidence implicates lipid metabolic dysregulation-spanning cholesterol efflux defects, sphingolipid imbalance, and peroxisomal dysfunction-as a convergent mechanism underlying OL differentiation failure and progressive demyelination in neurodegenerative diseases. This review explores the role of lipid metabolic rewiring in governing OPCs fate determination, highlighting three crucial axes: the interplay between mitochondria and peroxisomes in lipid biosynthesis, the potential toxicity of accumulated myelin debris in the microenvironment, and the regulation of OPC differentiation through lactylation modification on lipid metabolism and the interaction between glycolipid metabolisms. We further synthesize emerging therapeutic strategies targeting these pathways, including immunometabolism modulators, precision lipid interventions; diet-microbiome synergies: ketogenic diets combined with butyrate-producing probiotics to amplify endogenous remyelination. By integrating lipidomics datasets and recent clinical trial evidence, we propose a shift from broad metabolic suppression to spatially resolved modulation of lipid flux. This synthesis not only clarifies the dual roles of lipids in OL development and degeneration but also highlights druggable targets for personalized treatment of neurodegenerative diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neurodegenerative DiseasesLipid MetabolismOligodendrogliaHumansAnimalsMyelin SheathCell Differentiation

Stichwörter der Autor:innen

Lipid metabolismNeurodegenerative diseaseOligodendrocyteOligodendrocyte progenitor cellRemyelination

Autor:innen und Institutionen

  • National Engineering Laboratory for Resource Development of Endangered Crude Drugs in Northwest China, The Key Laboratory of Medicinal Resources and Natural Pharmaceutical Chemistry, The Ministry of Education, College o…
  • The Brain Science Center, Beijing Institute of Basic Medical Sciences, Beijing, 100850, China.
  • Huazhong University of Science and Technology Union Shenzhen Hospital, Shenzhen Nanshan Hospital, Shenzhen, Guangdong, 518052, China.

ORCID-Profile: Yuan Zhang, Xing Li

Förderung

  • National Natural Science Foundation of China
  • Scientific Research Program Funded by Education Department of Shaanxi Provincial Government
  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Sun, Q. Q., Bao, M. Y., Gao, R., Wang, S. K., Zhang, Y., Wang, L. B., Zhang, Y., & Li, X. (2026). Advances in understanding lipid metabolism in oligodendrocyte development and neurodegenerative diseases. Clinical Science. https://doi.org/10.1042/cs20258150

Vancouver

Sun QQ, Bao MY, Gao R, Wang SK, Zhang Y, Wang LB, et al. Advances in understanding lipid metabolism in oligodendrocyte development and neurodegenerative diseases. Clinical Science. 2026. doi:10.1042/cs20258150

BibTeX
@article{Sun2026,
  author = {Sun, Qing-Qing and Bao, Ming-Yue and Gao, Rui and Wang, Shu-Kun and Zhang, Yao and Wang, Li-Bin and Zhang, Yuan and Li, Xing},
  title = {Advances in understanding lipid metabolism in oligodendrocyte development and neurodegenerative diseases},
  journal = {Clinical Science},
  year = {2026},
  doi = {10.1042/cs20258150}
}
Kostenlos starten →